SELECT: Semaglutide Reduces Risk of MACE in Adults with Overweight or Obesity
Persistent glucose elevation damages peripheral nerves and disrupts microvascular circulation
Disclosures: Rohit Loomba, MD, is a consultant or advisory board member for Aardvark Therapeutics, Altimmune, Anylam/Regeneron, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Bristol-Myer Squibb, CohBar, Eli Lilly, Galmed, Gilead, Glympse bio, Hightide, Inipharma, Intercept, Inventiva, Ionis, Janssen Inc., Madrigal, Metacrine, Inc., NGM Biopharmaceuticals, Novartis, Novo Nordisk, Merck, Pfizer, Sagimet, Theratechnologies, 89 bio, Terns Pharmaceuticals and Viking Therapeutics
J Neurochem
GLP-1 medications are increasingly used to support weight loss
10.1016/j.obpill.2024.100127 37 GinesP.Serra-BurrielM.KamathP